Literature DB >> 4916914

Warfarin therapy. 1.

D Deykin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4916914     DOI： 10.1056/NEJM197009242831307

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Indications and techniques for the use of heparin in the treatment of thromboembolism.

Authors:  D Deykin
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

Review 2.  Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.

Authors:  S M MacLeod; E M Sellers
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Body mass index predicts major bleeding risks in patients on warfarin.

Authors:  Adedotun A Ogunsua; Sunkaru Touray; Justin K Lui; Tiffany Ip; Jorge V Escobar; Joel Gore
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

Review 4.  Pulmonary embolism: current therapeutic concepts.

Authors:  D A Tibbutt; C N Chesterman
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 5.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

6.  Clinical signs, laboratory changes and toxicokinetics of brodifacoum in the horse.

Authors:  H J Boermans; I Johnstone; W D Black; M Murphy
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

Review 7.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

8.  Effects of sodium warfarin on capillary ultrastructure.

Authors:  R A Kahn; S A Johnson; A F DeGraff
Journal:  Am J Pathol       Date:  1971-10       Impact factor: 4.307

9.  Warfarin: a review with emphasis on its use in the horse.

Authors:  A Vrins; G Carlson; B Feldman
Journal:  Can Vet J       Date:  1983-07       Impact factor: 1.008

Review 10.  Cardiovascular manifestations of hypereosinophilic syndromes.

Authors:  Princess U Ogbogu; Douglas R Rosing; McDonald K Horne
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.